Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer (SETICC)
This study is ongoing, but not recruiting participants.
Sponsor:
Spanish Cooperative Group for Gastrointestinal Tumour Therapy
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Spanish Cooperative Group for Gastrointestinal Tumour Therapy
ClinicalTrials.gov Identifier:
NCT01071655
First received: February 15, 2010
Last updated: February 19, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2014 |
| Primary Completion Date: | February 2012 (Final data collection date for primary outcome measure) |